Akebia Therapeutics, Inc.

AKBA Nasdaq SEC CIK 1517022
Follow Akebia Therapeutics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $36.9M −37.2% vs same quarter last year
Net income −$14.4M −2758.1% vs same quarter last year
EPS, diluted −$0.05
Operating cash flow $2.3M −91.7% vs same quarter last year
Revenue by quarter
$46.5M
$57.3M
$62.5M
$58.8M
$57.6M
$53.5M
$49.1M
$36.9M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$400M−$200M$0$200M$400MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$236.2M−$5.3M
FY24$160.2M−$69.4M
FY23$194.6M−$51.9M
FY22$292.5M−$94.2M
FY21$211.7M−$282M
FY20$294.6M−$384.8M
FY19$335M−$279.7M
FY18$207.7M−$143.6M
FY17$181.2M−$73.7M
FY16$1.5M−$135.7M
FY15$0−$60.7M
FY14$0−$37M
FY13-−$13.2M
FY12-−$8.2M
FY11--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−10000%−7500%−5000%−2500%0%2500%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2583.3%9.9%−2.2%
FY2460.6%−31.5%−43.3%
FY2361.9%−23.8%−26.7%
FY2270.7%−27.6%−32.2%
FY2128.8%−125%−133.2%
FY20−0.6%−128.2%−130.6%
FY1956.6%−85.5%−83.5%
FY1896.3%−85.8%−69.1%
FY17-−42.3%−40.7%
FY16-−8889.9%−8843.5%
FY15---
FY14---
FY13---
FY12---
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$300M−$200M−$100M$0$100MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$67.7M
FY24−$40.7M
FY23−$23.4M
FY22−$73.3M
FY21−$253M
FY20−$110.7M
FY19−$264.1M
FY18−$99.1M
FY17−$57.8M
FY16$55.2M
FY15−$52.8M
FY14−$27.7M
FY13−$11.4M
FY12-
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Akebia Therapeutics
  • Healthcare median
−10000%−7500%−5000%−2500%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearAkebia TherapeuticsHealthcare median
FY25−2.2%−30.6%
FY24−43.3%−47%
FY23−26.7%−58%
FY22−32.2%−80.4%
FY21−133.2%−71.8%
FY20−130.6%−62.2%
FY19−83.5%−46.2%
FY18−69.1%−49.6%
FY17−40.7%−45.9%
FY16−8843.5%−36%
FY15-−37.8%
FY14-−35.5%
FY13-−37.1%
FY12-−29.1%
FY11-−27.9%